噁拉戈利

ChemLeader 98+%

Elagolix (NBI-56418)

產品編號：CL2564 CAS No.：834153-87-6 MDLNo： 分子式：C32H30F5N3O5 分子量：631.59

加入收藏分享給朋友

規格	庫存	目錄價	會員專享價	數量
1 mg	3-5days	￥320.00	登錄后可見	- +
5 mg	3-5days	￥860.00	登錄后可見	- +
10 mg	3-5days	￥1350.00	登錄后可見	- +

化學品安全說明書(MSDS)

下載MSDS

發送詢價加入購物車

基本信息
相關文檔
產品詳情
相關文獻

基本信息

英文名稱	Elagolix (NBI-56418)
中文名稱	噁拉戈利
CAS號	834153-87-6
分子式	C32H30F5N3O5
分子量	631.59
外觀	White to off-white powder
儲存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產品詳情

Elagolix (formerly NBI56418; ABT620; NBI-56418; ABT-620; trade name: Orilissa) is a potent, specific, orally bioavailable, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) used for pain management. It inhibits GnRHR with a Kd of 54 pM. Elagolix was given FDA approval on July 23, 2018, to treat endometriosis-related moderate to severe pain. A short-acting GnRH antagonist, elagolix suppresses ovarian estrogen production in a dose-dependent manner, resulting in partial suppression at lower doses and complete suppression at higher doses. Because Elagolix is non-peptide and readily absorbed through the mouth, it is considered the leader of a new class of GnRH inhibitors known as second-generation inhibitors.

相關文獻

抱歉，暫時沒有相關文獻

相關產品

抱歉，暫時沒有相關產品

瀏覽記錄

CL2564

噁拉戈利

834153-87-6 98+% 3-5days

￥320.00 1 mg